Xiangdong Xu

Xiangdong Xu

Auto-generated profile, based on publicly available information

Xiangdong Xu

Department of Radiology, Guangzhou First People’s Hospital, Guangzhou, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
HYHuikang Yang
Huikang Yang
YMYingling Miao
Yingling Miao
LCLipeng Chen
Lipeng Chen
ZLZhuoran Li
Zhuoran Li
RYRuimeng Yang
Ruimeng Yang
XJxinqing jiang
xinqing jiang

4 June 2014 in Oncology Reports
Verified
Journal Article
Open access
PDF file
RYRui-Meng Yang
Rui-Meng Yang
YZYong Zou
Yong Zou
DHDan-Ping Huang
Dan-Ping Huang
SLSheng-Sheng Lai
Sheng-Sheng Lai
XXXiang-Dong Xu
Xiang-Dong Xu
XJxinqing jiang
xinqing jiang
The present study aimed to prospectively monitor the vascular disrupting effect of M410 by dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in rabbits with VX2 liver tumors. Twenty-eight rabbits bearing VX2 tumors in the left lobe of the liver were established and randomly divided into treatment and control groups, intravenously injected with 25 mg/kg M410 or sterile saline, respectively. Conventional and DCE-MRI data were acquired on a 3.0-T MR unit at pretreatment, 4 h, 1, 4, 7 and 14 days post-treatment. Histopathological examinations [hematoxylin and eosin (H&E) and CD34 immunohistochemisty staining] were performed at each time point. The dynamic changes in tumor volume, kinetic DCE-MRI parameter [volume transfer constant (Ktrans)] and histological data were evaluated. Tumors grew slower in the M410 group 4-14 days following treatment, compared with rapidly growing tumors in the control group (P<0.05). At 4 h, 1 and 4 days, Ktrans significantly decreased in the M410 group compared with that in the control group (P<0.05). However, Ktrans values were similar in the two groups for the other time points studied. The changes in DCE-MRI parameters were consistent with the results obtained from H&E and CD34 staining of the tumor tissues. DCE-MRI parameter Ktrans may be used as a non-invasive imaging biomarker to monitor the dynamic histological changes in tumors following treatment with the vascular targeting agent M410.

30 September 2022 in Internal and Emergency Medicine
Verified
Journal Article
Closed access
PDF file
JXJiajun Xie
Jiajun Xie
ACAmei Chen
Amei Chen
ZMZelan Ma
Zelan Ma
XXXiangdong Xu
Xiangdong Xu
XWXinhua Wei
Xinhua Wei

1 January 2021 in Canadian Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
PDF file
DHDanping Huang
Danping Huang
RYRuimeng Yang
Ruimeng Yang
YZYong Zou
Yong Zou
HLHongmei Lin
Hongmei Lin
XXXiangdong Xu
Xiangdong Xu
XJxinqing jiang
xinqing jiang
Objective. To investigate the treatment effect of a vascular‐disrupting agent, M410, using diffusion‐weighted imaging in a rabbit model of hepatic VX2 tumor. Methods. 28 New Zealand white rabbit models with VX2 liver tumors were established and were randomly divided into M410 (intravenous injection of M410 at a dose of 25 mg/kg every three days) and control (intravenous injection of saline every three days) groups. Conventional and diffusion‐weighted imaging (DWI) were acquired on a 3.0 T MR unit at baseline, 4 h, d 1, d 4, d 7, and d 14 posttreatment. B‐value with 700 (s/mm2) was chosen during DWI examinations. Tumor volume and apparent diffusion coefficient (ADC) values of the entire tumor and solid component of the tumor at every time point were measured. Two randomly chosen rabbits from each group were sacrificed for H&E staining and CD34 immunohistochemical assessments at each time point. An independent sample t‐test was used to assess differences in tumor sizes and ADC values of the entire tumor and solid component of tumors between two groups, with P < 0.05 considered statistically significant. Result. There was no significant difference in tumor volume between the two groups at baseline, 4 h, and d 1. With time, the tumors in the control group grew significantly faster than those in the M410 group, and the average ADC values of the M410 group were lower than those of the control group at d 1 and higher than those of the control group at d 4; as such, there were statistical differences between the two groups at these two time points but not at the other four time points. The following pathological results reflected the underlying morphological changes and vascular alterations. Conclusions. M410 performed well in inhibiting the growth of the hepatic VX2 tumor which could be noninvasively monitored by DWI metrics.